Procter & Gamble Health Share Price Target For Tomorrow, Next Week & Next Month
Procter & Gamble Health Limited | |||
 | Price: ₹6,243.50 (-1.4%) | ||
| 52 Week Low: ₹4,863.00 52 Week High: ₹6,739.00 | |||
| Market Capital: 7,962.64 Crore (Midcap) | |||
| Healthcare -> Drug Manufacturers - Specialty & Generic | |||
Procter & Gamble Health Stock Comparison: Procter & Gamble Health vs Strides Pharma Science | Procter & Gamble Health vs Wockhardt | Procter & Gamble Health vs Sun Pharma Advanced Research Company | Procter & Gamble Health vs Vijaya Diagnostic Centre | Procter & Gamble Health vs FDC | Procter & Gamble Health vs Medplus Health Services | |||
Show Table of Contents
Procter & Gamble Health Recent Performance
Over the past 455 trading days, the value of Procter & Gamble Health's stock has gained ₹1,117.40 (+21.80%). On 07 Nov 2023, one share was worth ₹5126.10 and by 12 Sep 2025, the value jumped to ₹6243.50. During this period it created a highest high of ₹6739.00 and lowest low of ₹4636.55.
Procter & Gamble Health Share Price Target - Tomorrow
| Level | Value | Analysis |
|---|---|---|
| Tomorrow Target 3 | 6809.98 (+9.07%) | Price Action: Chart |
| Tomorrow Target 2 | 6683 (+7.03%) | Price Action: 22 Aug 2025 High |
| Tomorrow Target 1 | 6550 (+4.9%) | Price Action: 04 Sep 2025 High |
| Current Price | 6243.50 | Procter & Gamble Health's share price as of 12 Sep 2025 |
| Stop Loss 1 | 6000 (-3.91%) | Price Action: 17 Jul 2025 High |
| Stop Loss 2 | 5936 (-4.93%) | Price Action: 21 Jul 2025 High |
| Stop Loss 3 | 5873 (-5.94%) | Price Action: 03 Jul 2025 High |
Summary
12 Sep 2025: Procter & Gamble Health finished the day at ₹6243.50, losing ₹-88.50 (-1.40%) in 1 day.
Our analysis for tomorrow predicts a potential movement of -5.93% to 9.07% with:
- Target prices: ₹6550 to ₹6809.98
- Support levels: ₹6000 to ₹5873
- Recent high: ₹6371.00
- Recent low: ₹6222.00
Stay ahead of the market! Get instant alerts on crucial market breakouts. Don't miss out on key opportunities!
Your phone number will be HIDDEN to other users.
Procter & Gamble Health Share Price Target - Next Week
| Level | Value | Analysis |
|---|---|---|
| Next Week Target 3 | 6484.93 (+3.86%) | Fibonacci Extension Level 64.90% |
| Next Week Target 2 | 6405 (+2.58%) | Price Action: 02 Sep 2025 High |
| Next Week Target 1 | 6331.29 (+1.4%) | Fibonacci Extension Level 23.60% |
| Current Price | 6243.50 | Procter & Gamble Health's share price as of 12 Sep 2025 |
| Stop Loss 1 | 6216 (-0.45%) | Price Action: 06 Aug 2025 High |
| Stop Loss 2 | 6152.5 (-1.46%) | Price Action: 13 Aug 2025 Low |
| Stop Loss 3 | 6082.5 (-2.58%) | Price Action: 07 Aug 2025 Low |
Weekly Target Summary
For next week, our analysis suggests a potential movement range of -2.58% to 3.87% with:
- Upper targets: ₹6331.29 to ₹6484.93
- Support levels: ₹6216 to ₹6082.5
Procter & Gamble Health Share Price Target - Next Month
| Level | Value | Analysis |
|---|---|---|
| Next Month Target 3 | 6739 (+7.93%) | Fibonacci Extension Level 100.00% |
| Next Month Target 2 | 6663.34 (+6.72%) | Fibonacci Extension Level 23.60% |
| Next Month Target 1 | 6594 (+5.61%) | Price Action: Sep 2025 High |
| Current Price | 6243.50 | Procter & Gamble Health's share price as of 12 Sep 2025 |
| Stop Loss 1 | 6152.5 (-1.46%) | Price Action: 13 Aug 2025 Low |
| Stop Loss 2 | 6082.5 (-2.58%) | Price Action: 07 Aug 2025 Low |
| Stop Loss 3 | 6010.5 (-3.74%) | Price Action: 25 Jun 2025 High |
Monthly Target Summary
Looking ahead to next month, technical analysis indicates:
- Potential price movement: -3.73% to 7.94% with:
- Target range: ₹6594 to ₹6739
- Support levels: ₹6152.5 to ₹6010.5
Disclaimer: The information provided on this page is for educational purposes only and should not be considered as financial advice. Historical performance data and technical analysis cannot guarantee future results. Stock investments are subject to market risks. Please consult with a qualified financial advisor before making any investment decisions.
All stock data shown is sourced from publicly available information and while we strive for accuracy, we cannot guarantee the absolute accuracy of all figures. Users should verify critical information from official sources before making investment decisions.
